Controlling for factors like body size and muscle mass, researchers found that there are basically four phases of metabolic rates, and that a slowdown in adults doesn’t occur until after age 60.
Rethinking medical care: Dr. Samuel Klein and collaborators seek to understand how and why some obese individuals are able to retain metabolic and cardiovascular health.
In the first clinical trial of nicotinamide mononucleotide, School of Medicine researchers have found that the compound previously demonstrated to counteract aspects of aging and improve metabolic health in mice also has clinically relevant effects in people.
Study finds that metabolic benefits of weight loss in severely obese people are the same whether they lose excess pounds through dieting or surgery.
On WNYC’s The Takeaway, Samuel Klein, MD, director of the Center for Human Nutrition at Washington University School of Medicine in St. Louis, discusses the science of America’s obesity epidemic.